MRUS logo

Merus NV (MRUS) Company Overview

Profile

Full Name:

Merus N.V.

Sector:

Healthcare

Industry:

Biotechnology

Country:

Netherlands

IPO:

May 19, 2016

Indexes:

Not included

Description:

Merus NV is a biotechnology company focused on developing innovative therapies for cancer. They create bispecific antibodies that can target multiple cancer cells simultaneously, aiming to improve treatment effectiveness and patient outcomes. Their research is centered on advancing personalized medicine in oncology.

Key Details

Price

$47.13

Annual Revenue

$36.13 M(-17.78% YoY)

Annual EPS

-$3.35(-11.67% YoY)

Annual ROE

-42.88%

Beta

0.91

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Feb 28, 2025

Recent annual earnings:

Feb 28, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Mar 3, 25 HC Wainwright & Co.
Buy
Feb 28, 25 Needham
Buy
Feb 13, 25 Piper Sandler
Overweight
Feb 12, 25 Guggenheim
Buy
Dec 10, 24 Citigroup
Buy
Dec 9, 24 Needham
Buy
Dec 5, 24 Needham
Buy
Dec 5, 24 HC Wainwright & Co.
Buy
Dec 5, 24 Guggenheim
Buy
Dec 3, 24 Guggenheim
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Merus NV?
  • Does Merus NV pay dividends?
  • What sector is Merus NV in?
  • What industry is Merus NV in?
  • What country is Merus NV based in?
  • When did Merus NV go public?
  • Is Merus NV in the S&P 500?
  • Is Merus NV in the NASDAQ 100?
  • Is Merus NV in the Dow Jones?
  • When was Merus NV's last earnings report?
  • When does Merus NV report earnings?
  • Should I buy Merus NV stock now?

What is the ticker symbol for Merus NV?

The ticker symbol for Merus NV is NASDAQ:MRUS

Does Merus NV pay dividends?

No, Merus NV does not pay dividends

What sector is Merus NV in?

Merus NV is in the Healthcare sector

What industry is Merus NV in?

Merus NV is in the Biotechnology industry

What country is Merus NV based in?

Merus NV is headquartered in Netherlands

When did Merus NV go public?

Merus NV's initial public offering (IPO) was on May 19, 2016

Is Merus NV in the S&P 500?

No, Merus NV is not included in the S&P 500 index

Is Merus NV in the NASDAQ 100?

No, Merus NV is not included in the NASDAQ 100 index

Is Merus NV in the Dow Jones?

No, Merus NV is not included in the Dow Jones index

When was Merus NV's last earnings report?

Merus NV's most recent earnings report was on Feb 28, 2025

When does Merus NV report earnings?

The date for Merus NV's next earnings report has not been announced yet

Should I buy Merus NV stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions